Barriers to accessing EC in Italy

In a new study published in The Kennedy Institute of Ethics Journal, Italian researchers explore the empirical and theoretical reasons behind why doctors and pharmacists may refuse to provide women with EC. Although evidence suggests that refusal typically is based on grounds of conscious, the researchers argue that the category of conscientious objection is not the most appropriate one for making sense of these claims because they are not grounded in a conflict between two contrasting moral duties. Since EC is available only by prescription from pharmacies in Italy, the researchers propose that the seemingly forced choice between protecting doctors’ and pharmacists’ professional self-determination and women’s reproductive self-determination could be prevented by distributing EC without a prescription and in a number of outlets in addition to pharmacies, thus relieving doctors and pharmacists from the legal duty to provide it.

Similar Posts

  • In the UK, BPAS launches campaign to reduce the cost of EC pills

    The UK organisation BPAS, launched a campaign that calls on pharmacies to reduce the cost of EC pills. As stated in ECEC´s last update on access to EC in Europe, the prices for both LNG and UPA EC pills when procured directly at the pharmacy in certain regions of the United Kingdom and in Ireland, are the higher in…

  • Global: WHO launches new Maternal Mortality Estimates

    April 2025. The United Nations Maternal Mortality Estimation Inter-Agency Group (MMEIG) and technical experts published a new round of estimates covering 2000 to 2023. The estimates represent the most up to date, internationally comparable global, regional and country-level estimates and trends for maternal mortality between 2000 and 2023. Some key facts: Find the Full Report…

  • New EC guidelines in Croatia

    Following three months of public debate, in September 2015, the Croatian Society of Gynecologic Endocrinology and Human Reproduction (HDGEHR), the Croatian Society of Gynecology (HDGO), and the Gynecology Primary Practice Section of the Croatian Medical Association issued national guidelines on oral emergency contraception. To read the full guidelines in Croatian, please click here. This document…

  • Review of uses of UPA beyond EC

    March 2025. A new article describes uses of ulipristal acetate (UPA) beyond emergency contraception: Uses of ulipristal acetate beyond emergency contraception: a narrative review (Ebersole, Ashley M. et al. Contraception). The review describes the extensive potential for UPA to treat and/or prevent conditions such as fibroids, breast cancer, and abnormal uterine bleeding, in addition to other…

  • Argentina: New data on EC use and access

    November 2024. The Study Lucía: Uses and preferences of contraceptive methods in women aged 15 to 49 years in Argentina, was recently published. This quantitative and qualitative research has consulted 2,000 women and people identifyin as LGTB from all over the nation. The study findings, published in September 2024, include valuable information about access to…